174 related articles for article (PubMed ID: 1649270)
1. Ifosfamide, Fanconi's syndrome, and rickets.
Pratt CB; Meyer WH; Jenkins JJ; Avery L; McKay CP; Wyatt RJ; Hancock ML
J Clin Oncol; 1991 Aug; 9(8):1495-9. PubMed ID: 1649270
[TBL] [Abstract][Full Text] [Related]
2. Ifosfamide-induced renal tubular dysfunction and rickets in children with Wilms tumor.
Burk CD; Restaino I; Kaplan BS; Meadows AT
J Pediatr; 1990 Aug; 117(2 Pt 1):331-5. PubMed ID: 2166154
[TBL] [Abstract][Full Text] [Related]
3. Refining therapeutic strategies for patients with resistant Wilm's tumor.
Marina NM; Wilimas JA; Meyer WH; Jones DP; Douglass EC; Pratt CB
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):296-300. PubMed ID: 7978044
[TBL] [Abstract][Full Text] [Related]
4. Fanconi's syndrome due to ifosfamide.
Beckwith C; Flaharty KK; Cheung AK; Beatty PG
Bone Marrow Transplant; 1993 Jan; 11(1):71-3. PubMed ID: 8431714
[TBL] [Abstract][Full Text] [Related]
5. [Ifosfamide-induced nephrotoxicity].
Rossi R; Rath B; Ullrich K; Ehrich JH
Monatsschr Kinderheilkd; 1993 Jul; 141(7):594-601. PubMed ID: 8413339
[TBL] [Abstract][Full Text] [Related]
6. Fanconi's syndrome and nephrogenic diabetes insipidus in an adult treated with ifosfamide.
Ingemi AI; Bota VM; Peguero A; Charpentier M
Pharmacotherapy; 2012 Jan; 32(1):e12-6. PubMed ID: 22392832
[TBL] [Abstract][Full Text] [Related]
7. Long-term follow-up of ifosfamide renal toxicity in children treated for malignant mesenchymal tumors: an International Society of Pediatric Oncology report.
Suarez A; McDowell H; Niaudet P; Comoy E; Flamant F
J Clin Oncol; 1991 Dec; 9(12):2177-82. PubMed ID: 1720453
[TBL] [Abstract][Full Text] [Related]
8. Ifosfamide-induced Fanconi's syndrome with growth failure in a 2-year-old child.
De Schepper J; Stevens G; Verboven M; Baeta C; Otten J
Am J Pediatr Hematol Oncol; 1991; 13(1):39-41. PubMed ID: 2029077
[TBL] [Abstract][Full Text] [Related]
9. The development of rickets as a complication of chemotherapy for the treatment of Wilms' tumor.
Segal LS; Palumbo RC; Robertson WW
Orthopedics; 1995 Mar; 18(3):261-4. PubMed ID: 7761316
[TBL] [Abstract][Full Text] [Related]
10. Unilateral nephrectomy and cisplatin as risk factors of ifosfamide-induced nephrotoxicity: analysis of 120 patients.
Rossi R; Gödde A; Kleinebrand A; Riepenhausen M; Boos J; Ritter J; Jürgens H
J Clin Oncol; 1994 Jan; 12(1):159-65. PubMed ID: 8270973
[TBL] [Abstract][Full Text] [Related]
11. [Nephropathy in patients treated with ifosfamide].
Kiss K; Nagy K; Hunyadi K; Simkó R
Orv Hetil; 1994 May; 135(19):1023-6. PubMed ID: 8183542
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of the acute nephrotoxicity from standard dose cisplatin +/- ifosfamide and high-dose chemotherapy with carboplatin and ifosfamide.
Hartmann JT; Fels LM; Franzke A; Knop S; Renn M; Maess B; Panagiotou P; Lampe H; Kanz L; Stolte H; Bokemeyer C
Anticancer Res; 2000; 20(5C):3767-73. PubMed ID: 11268452
[TBL] [Abstract][Full Text] [Related]
13. Acute pancreatitis after ifosfamide therapy.
Izraeli S; Adamson PC; Blaney SM; Balis FM
Cancer; 1994 Sep; 74(5):1627-8. PubMed ID: 8062195
[TBL] [Abstract][Full Text] [Related]
14. Concentrating capacity in ifosfamide-induced severe renal dysfunction.
Rossi R; Gödde A; Kleinebrand A; Rath B; Jürgens H
Ren Fail; 1995 Sep; 17(5):551-7. PubMed ID: 8570867
[TBL] [Abstract][Full Text] [Related]
15. Ifosfamide tolerance in osteosarcoma patients previously treated with cis-diamminedichloroplatinum-II: renal, hematologic, and neurologic observations.
Canpolat C; Pearson P; Robertson R; Jaffe N
Med Pediatr Oncol; 1996 Jan; 26(1):36-47. PubMed ID: 7494510
[TBL] [Abstract][Full Text] [Related]
16. [Nephrotoxicity of ifosfamide with special reference to Fanconi Syndrome].
Rogowska E; Woźniak W
Med Wieku Rozwoj; 2004; 8(2 Pt 1):289-95. PubMed ID: 15738605
[TBL] [Abstract][Full Text] [Related]
17. Renal failure does not preclude cure in children receiving chemotherapy for Wilms tumor: a report from the National Wilms Tumor Study Group.
Feusner JH; Ritchey ML; Norkool PA; Takashima JR; Breslow NE; Green DM
Pediatr Blood Cancer; 2008 Feb; 50(2):242-5. PubMed ID: 17458877
[TBL] [Abstract][Full Text] [Related]
18. Rickets--a complication of ifosfamide chemotherapy for Wilms tumor.
Relf M; Boal DK
Pediatr Radiol; 1992; 22(3):209-10. PubMed ID: 1324461
[TBL] [Abstract][Full Text] [Related]
19. Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial.
Meyer WH; Pratt CB; Poquette CA; Rao BN; Parham DM; Marina NM; Pappo AS; Mahmoud HH; Jenkins JJ; Harper J; Neel M; Fletcher BD
J Clin Oncol; 2001 Jan; 19(1):171-82. PubMed ID: 11134210
[TBL] [Abstract][Full Text] [Related]
20. [Successful treatment of metastatic and refractory osteosarcoma by ifosfamide, carboplatin and vindesine: case report].
Fujita H; Kiyokawa N; Takada K; Kyo K; Ishimoto K; Yabuta K; Mizuno T
Gan To Kagaku Ryoho; 1991 Sep; 18(12):2167-70. PubMed ID: 1888188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
